在一般实践中减少短效β-激动剂的过度处方:东伦敦质量改善计划的评估
Anna De Simoni1, Hajar Hajmohammadi1, Paul Pfeffer2
1Wolfson Institute of Population Health, Centre for Applied Respiratory Research, Innovation, and Impact (CARRii), Queen Mary University of London, London, UK.
The European journal of general practice
|February 2, 2026
概括
随着质量改善计划的实施,短效β-激动剂 (SABA) 吸入剂的过度处方减少了. 电子警报和实践指导有效地减少了喘患者过度使用SABA的情况.
科学领域:
- 呼吸系统医学 呼吸系统医学
- 医疗保健服务研究 医疗服务研究
- 提高质量 提高科学 提高质量
背景情况:
- 短效β-激动剂 (SABA) 吸入剂的过度处方是一个重大的全球健康问题.
- 解决SABA过度使用对于改善喘管理和患者的治疗结果至关重要.
研究的目的:
- 评估全系统质量改进计划在减少SABA过度处方方面的有效性.
- 确定有助于成功减少SABA过度使用的关键策略.
主要方法:
- 在东伦敦的一般实践中实施了一项质量改进计划 (2020年10月至2023年3月),邻近的区作为比较器.
- 干预措施包括对高SABA处方的电子警报,患者审查列表,临床指南和患者传单.
- 处方数据分析使用中断时间序列,并补充了员工反的定性内容分析.
主要成果:
- 在干预实践中观察到,喘患者每年处方>6个SABA吸入器的数量显著减少.
- 电子处方警报被证明是有效的,50%的目标患者将SABA使用量减少到<12个吸入器/年.
- 由于COVID-19大流行,喘登记的患者数量暂时增加了6个月.
结论:
- 质量改进计划成功减少了SABA的过度使用,可能降低了入院率.
- 个性化指导对于有效使用电子工具至关重要.
- 综合的处方警报和协作实践文化加速了减少策略的实施.
相关概念视频
Direct-Acting Cholinergic Agonists: Pharmacokinetics
1.9K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.9K
Direct-Acting Cholinergic Agonists: Therapeutic Uses
1.7K
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
1.7K
Indirect-Acting Cholinergic Agonists: Pharmacokinetics
1.6K
Indirect-acting cholinergic agonists, or anticholinesterases, enhance the body's cholinergic activity by inhibiting acetylcholine's breakdown. They are categorized as reversible or irreversible agents based on their mechanism of action. They are further classified into short-acting, intermediate-acting, and long-acting agents based on their duration of action.
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
1.6K
Adrenergic Agonists: Direct-Acting Agents
2.8K
Drugs that mimic the action of endogenous catecholamines like noradrenaline and adrenaline are called adrenergic agonists or sympathomimetics. Based on their mechanism of action, sympathomimetics can be classified as direct-, indirect-, or mixed-acting sympathomimetics. Direct-acting adrenergic agonists activate adrenoceptors without affecting presynaptic neurons, making them independent of neuronal catecholamine-depleting agents like reserpine and guanethidine.
These agents can be classified...
These agents can be classified...
2.8K
Adrenergic Agonists: Indirect-Acting Agents
2.7K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
2.7K
Direct-Acting Cholinergic Agonists: Pharmacological Actions
2.3K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
2.3K


